MODIFIZIERTE NUKLEOTID-LINKER

European patent · EP3177634 · In force

Register entry

Publication number
EP3177634
Application number
EP15750100
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 6, 2015
Published
Jun 14, 2017
Granted
Dec 18, 2019
Protection ends at the latest
Aug 5, 2035
Next annual fee due
Aug 31, 2026
IPC classes
C07H 19/14 (2006.01)
Priority
GB 201414098 08.08.2014
PCT application
PCT/GB2015/052282 06.08.2015
PCT publication
WO2016/020691 11.02.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  5. May 27, 2021

    Address changed

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève → Murgitroyd & Company, 4, Rue du Commerce, 1204 Genève

    Published in Swissreg on 27.05.2021

  6. Mar 11, 2020

    Agent entered

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève

    Published in Swissreg on 11.03.2020

  7. Dec 18, 2019

    Granted

    Published in Swissreg on 18.12.2019

Parties

Holder

Illumina Cambridge Limited

19 Granta Park Great Abington, Cambridge CB21 6DF, GB

Agent

Murgitroyd & Company

4, Rue du Commerce, 1204 Genève

Inventor

WU, Xiaolin

Essex CB10 1XL, GB

LIU, Xiaohai

Essex CB10 1XL, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.